维库溴铵杂质E, Vecuronium Bromide EP Impurity E

(5-氯-1H-吲哚-2-基)甲醇, (5-Chloro-1H-indol-2-yl)methanol

4-甲基苯并[d][1,2,5]噁二唑, 4-Methylbenzo[c][1,2,5]oxadiazole

5-氟-1H-吡咯并[2,3-b]吡啶-3-羧酸, 5-Fluoro-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid

(S)-2-(氰基甲基)哌嗪-1-羧酸苄酯, Benzyl (S)-2-(cyanomethyl)piperazine-1-carboxylate

(S)- 双(4-甲氧基苯基)(吡咯烷-2-基)甲醇, (S)-Bis(4-methoxyphenyl)(pyrrolidin-2-yl)methanol

(R)-1-苄基-4-叔丁基2-(羟甲基)哌嗪-1,4-二羧酸酯, (R)-1-Benzyl 4-tert-butyl 2-(hydroxymethyl)piperazine-1,4-di

6,7-二氢-1H-咪唑并[4,5-c]吡啶-1,5(4H)-二羧酸二叔丁酯, di-tert-Butyl 6,7-dihydro-1H-imidazo[4,5-c]pyridine-1,5(4H)-

3-[[(1R,2R)-2-(1-哌啶基)环己基]氨基]-4-[[4-(三氟甲基)苯基]氨基]-3-环丁烯-1,2-二酮, 3-[[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(triflu

利奈唑胺杂质33, Linezolid Impurity 33